Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Solazyme Inc (NASDAQ:TVIA) fell as much as 10.6% today after the company reported first-quarter earnings.
So what: Revenue was up 85% to $12.4 million but net loss increased from $26.5 million a year ago to $34.7 million last quarter. Even on a non-GAAP basis, the loss of $30.5 million equated to $0.44 per share, which was much higher than the $0.33 loss analysts expected.
Now what: Solazyme has long been a company with a lot of promise, and management pointed to progress in Clinton/Galva, the encapsulated lubricant Encapso, and Algenist. But Solazyme isn't anywhere close to leading to a profit, and analysts have high expectations for the company this year and next. Analysts have estimated revenue of $115.2 million in 2014 and $330.4 million next year, so Solazyme needs to pick up production to keep investors happy, something it clearly didn't do fast enough in the first quarter.
Travis Hoium has no position in any of the stocks mentioned. The Motley Fool owns shares of Solazyme. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insightsmakes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
TerraVia Announces Bankruptcy and Asset Sale
Months ago, the ingredients and chemical manufacturer said it was exploring its options. Today we know how the story ends.
TerraVia Announces First-Quarter 2017 Results and a Plan to (Maybe) Sell Itself
While still on track to reach its 2017 goals, the microalgae oil pioneer is preparing for other potential outcomes.
TerraVia Completes Pivot to Food and Specialty Ingredients. What's Ahead in 2017?
The company reported fourth-quarter and full-year 2016 earnings.